Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD on Immune Nutrisoda

This article was originally published in The Tan Sheet

Executive Summary

PepsiAmericas subsidiary Ardea Beverages will discontinue a print advertisement for Immune Nutrisoda following a determination by the National Advertising Division that "the advertisement went beyond simple structure/function claims." The ad, which featured images of a can of the product and an airplane, stated "protection from seat 33b." Other claims in the ad included "Immune Nutrisoda doesn't just refresh you, it revitalizes you....It's full of the right stuff to help support your body's immune defenses." The images and statements in the spot "combine to convey a message that this product will do more than simply provide vitamins and minerals that will help to maintain a healthy immune system," NAD concludes in a Nov. 21 decision. Ardea "respectfully disagrees" with NAD's assessment, but says it will take the suggestions into consideration in planning future advertisements...

You may also be interested in...



Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California

US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.

Execs On The Move: Medical Microinstruments Gets New CEO; Changes At iRhythm; Aethlon Makes A Promotion

Corindus Vascular Robotics CEO made a lateral move to Medical Microinstruments; iRhythm hires a new CEO, while the former CEO stays on as a director; Aethlon promotes a director to chief business officer; and more.

NANS 2021: Boston Scientific Advances New Personalized Pain Therapy

Boston Scientific’s WaveWriter Alpha spinal cord stimulation devices feature the proprietary FAST software for rapid, paresthesia-free pain relief of chronic pain.

Topics

UsernamePublicRestriction

Register

OM014079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel